CSL (ASX:CSL; USOTC:CSLLY) has announced that the U.S. Food and Drug Administration (FDA) has approved ANDEMBRY® for immediate launch across the United States. ANDEMBRY® is now officially authorized as a preventive treatment for hereditary angioedema (HAE) in adult and pediatric patients aged 12 years …

Vanadium Resources Limited (ASX:VR8) witnessed a sharp rise in its share price, surging 157% to 3.6 cents on 17 June 2025, following the announcement of a Memorandum of Understanding (MoU) between its wholly owned subsidiary, Vanadium Resources (Pty) Limited (VanRes), and China Precious Asia …

Finder Energy (ASX:FDR) has announced the execution of a Development Alliance Agreement with global energy technology company SLB to jointly progress the KTJ Project. Alongside this, the companies have entered into an Accelerated Front End Engineering and Design (FEED) Project Agreement to advance critical …

The takeover tussle for ASX-listed bookmaker PointsBet (ASX:PBH) intensified this week as Betr (ASX:BBT), a competing Australian bookie and the largest shareholder in PointsBet, publicly rejected claims that its offer is inferior to that of Japanese bidder Mixi. Betr, which currently holds a 19.9% …